Similarly, in a limited population of prostate cancer patients studied, low phosphorylation levels of the STAT5A substrate by tumors from ADT-naïve patients’ were revealed, whereas the STAT5A phosphorylation level generated by the tumor from an early CR disease case was substantially higher. The gene discussed is STAT5A; the disease is neoplasm.